Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Avidity Biosciences (RNA) Return on Sales (2020 - 2025)

Historic Return on Sales for Avidity Biosciences (RNA) over the last 7 years, with Q3 2025 value amounting to 13.95%.

  • Avidity Biosciences' Return on Sales rose 203600.0% to 13.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 26.29%, marking a year-over-year increase of 13800.0%. This contributed to the annual value of 29.55% for FY2024, which is 74200.0% down from last year.
  • Per Avidity Biosciences' latest filing, its Return on Sales stood at 13.95% for Q3 2025, which was up 203600.0% from 40.72% recorded in Q2 2025.
  • Avidity Biosciences' 5-year Return on Sales high stood at 8.82% for Q1 2021, and its period low was 73.32% during Q1 2025.
  • For the 5-year period, Avidity Biosciences' Return on Sales averaged around 24.71%, with its median value being 20.23% (2023).
  • Over the last 5 years, Avidity Biosciences' Return on Sales had its largest YoY gain of 203600bps in 2025, and its largest YoY loss of -539200bps in 2025.
  • Avidity Biosciences' Return on Sales (Quarter) stood at 20.78% in 2021, then increased by 12bps to 18.22% in 2022, then plummeted by -51bps to 27.51% in 2023, then decreased by -25bps to 34.46% in 2024, then surged by 60bps to 13.95% in 2025.
  • Its Return on Sales stands at 13.95% for Q3 2025, versus 40.72% for Q2 2025 and 73.32% for Q1 2025.